Working... Menu

Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma (PRIMAIN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00989352
Recruitment Status : Unknown
Verified October 2009 by University Hospital Freiburg.
Recruitment status was:  Recruiting
First Posted : October 5, 2009
Last Update Posted : October 5, 2009
Universitätsklinikum Köln
Ludwig-Maximilians - University of Munich
University Hospital Heidelberg
University Hospital Ulm
Information provided by:
University Hospital Freiburg